Cooper Total Liabilities and Share Holders Equity 2010-2024 | COO
Cooper total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Cooper total liabilities and share holders equity for the quarter ending July 31, 2024 was $12.108B, a 3.51% increase year-over-year.
- Cooper total liabilities and share holders equity for 2023 was $11.659B, a 1.45% increase from 2022.
- Cooper total liabilities and share holders equity for 2022 was $11.492B, a 19.63% increase from 2021.
- Cooper total liabilities and share holders equity for 2021 was $9.606B, a 42.58% increase from 2020.
Cooper Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$11,659 |
| 2022 |
$11,492 |
| 2021 |
$9,606 |
| 2020 |
$6,738 |
| 2019 |
$6,275 |
| 2018 |
$6,113 |
| 2017 |
$4,859 |
| 2016 |
$4,479 |
| 2015 |
$4,460 |
| 2014 |
$4,458 |
| 2013 |
$3,137 |
| 2012 |
$2,941 |
| 2011 |
$2,625 |
| 2010 |
$2,525 |
| 2009 |
$2,552 |
Cooper Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-07-31 |
$12,108 |
| 2024-04-30 |
$12,047 |
| 2024-01-31 |
$12,033 |
| 2023-10-31 |
$11,659 |
| 2023-07-31 |
$11,697 |
| 2023-04-30 |
$11,540 |
| 2023-01-31 |
$11,561 |
| 2022-10-31 |
$11,492 |
| 2022-07-31 |
$11,552 |
| 2022-04-30 |
$11,778 |
| 2022-01-31 |
$11,663 |
| 2021-10-31 |
$9,606 |
| 2021-07-31 |
$9,611 |
| 2021-04-30 |
$9,014 |
| 2021-01-31 |
$8,922 |
| 2020-10-31 |
$6,738 |
| 2020-07-31 |
$6,748 |
| 2020-04-30 |
$6,510 |
| 2020-01-31 |
$6,549 |
| 2019-10-31 |
$6,275 |
| 2019-07-31 |
$6,173 |
| 2019-04-30 |
$6,203 |
| 2019-01-31 |
$6,299 |
| 2018-10-31 |
$6,113 |
| 2018-07-31 |
$6,257 |
| 2018-04-30 |
$6,414 |
| 2018-01-31 |
$6,269 |
| 2017-10-31 |
$4,859 |
| 2017-07-31 |
$4,783 |
| 2017-04-30 |
$4,750 |
| 2017-01-31 |
$4,657 |
| 2016-10-31 |
$4,479 |
| 2016-07-31 |
$4,593 |
| 2016-04-30 |
$4,601 |
| 2016-01-31 |
$4,402 |
| 2015-10-31 |
$4,460 |
| 2015-07-31 |
$4,423 |
| 2015-04-30 |
$4,393 |
| 2015-01-31 |
$4,336 |
| 2014-10-31 |
$4,458 |
| 2014-07-31 |
$3,367 |
| 2014-04-30 |
$3,222 |
| 2014-01-31 |
$3,115 |
| 2013-10-31 |
$3,137 |
| 2013-07-31 |
$3,007 |
| 2013-04-30 |
$2,967 |
| 2013-01-31 |
$2,970 |
| 2012-10-31 |
$2,941 |
| 2012-07-31 |
$2,884 |
| 2012-04-30 |
$2,629 |
| 2012-01-31 |
$2,599 |
| 2011-10-31 |
$2,625 |
| 2011-07-31 |
$2,615 |
| 2011-04-30 |
$2,625 |
| 2011-01-31 |
$2,572 |
| 2010-10-31 |
$2,525 |
| 2010-07-31 |
$2,503 |
| 2010-04-30 |
$2,509 |
| 2010-01-31 |
$2,521 |
| 2009-10-31 |
$2,552 |
| 2009-07-31 |
$2,581 |
| 2009-04-30 |
$2,546 |
| 2009-01-31 |
$2,551 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$22.013B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
